Healthcare Services
Specialty Pharmacy
M&A Intelligence Hub
Five strategic insights on the specialty pharmacy M&A landscape, applied through the Prime Architecture™ Method and the Battle-Ready Index™.
Typical Revenue (LMM)
$15M–$120M
5–12% EBITDA margins
EBITDA Multiples
6x–13x
Mid-band: 9x
Transferability Risk
MEDIUM
Platform activity: Active.
The five insights
-
For buy-side · ETA · IS
Buying a Specialty Pharmacy Business
The Strategic Capacity playbook. Pre-LOI diligence framework, BRI factors, what the financials cannot tell you.
-
For sell-side · Operator CEOs
Selling a Specialty Pharmacy Business
The architecture of a premium exit. Value Gap math, BRI applied, the 18-month transformation roadmap.
-
For both sides
The Specialty Pharmacy Value Gap
How transferable value leaks in specialty pharmacy deals, and the architecture that closes the gap.
-
For acquirers · post-close
Integration in Specialty Pharmacy Acquisitions
Day-1 through day-365 integration architecture. Where deals fail and the substrate that saves them.
-
For advisors · IBs · lenders
Specialty Pharmacy M&A Diligence Playbook
The Strategic Capacity diligence layer. Runs alongside QoE. Pre-LOI viable.